Posts Tagged ‘albendazole’

New plan to eliminate NTDs in Kenya

November 10th, 2011

Mass drug administration of Albendazole in conjunction with the launch of the Kenyan national plan for NTD control and elimination.

“Africa bears 50% of the global burden of neglected tropical diseases.” Quoted from an article published in Africa Science News, neglected tropical diseases (NTDs) are perpetuating the cycle of poverty,  prohibiting African populations from reaching their potential. In Kenya alone, 1 in 2 people suffer from NTDs. Recognizing this burden, the Kenyan government has launched a five-year long national plan to address NTDs such as schistosomiasis, trachoma, leishmaniasis, intestinal worms, elephantiasis and Hydatid disease. Kenya is the first African country to launch such a plan, which will bring the country closer to becoming free from preventable diseases. Eliminating NTDs in  Kenya is also in line with Millennium Development Goal 6, along with achieving Vision 2030, which aims to turn Kenya into a middle-income nation by 2030.

Read more about Kenya’s national NTD plan on Africa Science News.

Medical Brigade in rural Ecuador

March 29th, 2011

By: Linda Diep

Students singing the Ecuadorian national anthem.

For my Springbreak this semester, I had the opportunity to go on a public health service trip to Riobamba, Ecuador. I went with a group of twenty-nine undergraduate and graduate students from the George Washington University for a 10-day trip setting up makeshift clinics in various rural areas of Riobamba.  As a local chapter of MedLife, a nonprofit based in New York that provides sustainable healthcare solutions through mobile clinics to poverty-stricken areas in Peru, Ecuador, and Panama, our group saw an estimated 500 patients during our medical brigade.

During the week, we visited five different grade schools where we setup the clinics to address the basic health needs of the local people. We were accompanied by three physicians and a pharmacist, all natives of Ecuador. The clinics contained stations that volunteers rotated positions each day. One day, you would shadow the dentist and assist her in extracting teeth, while the next day you were at the pharmacy where you would cut pills and instruct patients on dosage and treatment.

Patients coming into the clinic.

We saw an average of 100 patients a day. Common ailments suffered by those coming through included Type 2 diabetes among the adults and malnutrition, vitamin deficiency, and burns and fungus due to the harsh climate among the children.

Albendazole available at the pharmacy.

Present in the pharmacy was albendazole, a drug to treat several of the seven most common neglected tropical diseases (NTDs) such as ascariasis (roundworm), trichuriasis (whipworm), and hookworm. Several of the child patients were prescribed albendazole by the internal medicine physician, however, worm infestation was not as prevalent among the population as the aforementioned health conditions.

The patients were very welcoming, and showed their appreciation through friendly handshakes, kind words, and gifts in the form of food. Age groups of patients spanned from infancy to about 15 years old, and 45 to 65 years old. One patient was as old as 91. Mostly women were seen.

Volunteer takes a patient's temperature at vitals station.

My favorite station of the week was the vitals station. Each patient that came through had to stop at this station to document their weight, height, blood pressure, and temperature. Thus, I was able to talk to every individual that passed through that day. The conversations and small banter exchanged were very rewarding, and solidified the feeling that we were actually making an impact.

The trip reminded me that providing basic healthcare is a fundamental part of the continuum of care. Thus, it is essential to treat diseases such as NTDs which contribute to the cycle of poverty. To do your part, visit our “Get Involved” page on the Global Network website, or join the conversation on Twitter and Facebook.

Worm of the Week – Lymphatic Filariasis

August 24th, 2010

Another installment from our Worm of the Week series, courtesy of student campaigners from Boston University! Today we feature:

Lymphatic Filariasis


Wuchereria bancrofti AND Brugia malayi AND Brugia timori

Lymphatic Filariasis

A physically and socially debilitating disease, lymphatic filariasis affects over 120 million people in 80 different countries. The thread-like parasitic filarial worms, Wuchereria bancrofti (causing most infections worldwide), and Brugia malayi and Brugia timori (primarily in Asia) lodge in the human lymphatic system. There, adult worms mate and produce millions of microscopic microfilariae that circulate in the person’s blood. Infection spreads by mosquito bites containing larval worms that travel to lymph and grow into adults which takes about six months. Adult worms can live 5 to 7 years.

Symptoms

Sometimes called elephantiasis due to the engorgement and thickening of skin, lymphatic filariasis is characterized by lymphedema, or fluid collection due to improper functioning of the lymph system resulting in swelling. Most infected individuals are asymptomatic and will never develop symptoms. In the severest cases, fluid accumulates in the legs, arms, breasts, and genitalia. Infected persons are at increased risk for bacterial infections in the skin and lymph system.

Diagnosis

Microscopic identification of microfilariae in blood smear. Blood collection should be done at night.

Treatment

Diethylcarbamazine (DEC) kills microfilaria and some of the adult worms; Ivermectin kills microfilaria.

Prevention and Control

The best way to avoid lymphatic filariasis is to avoid mosquito bites (sleep under mosquito net, use repellent, wear long sleeves and trousers). In 1997, the World Health Assembly called for the global elimination of lymphatic filariasis as a public health problem. The strategy for elimination is based on treating everyone eligible to take the medicine living in an affected community with a dose of two drugs: albendazole is used in conjunction with ivermectin (sub-Saharan Africa) and with DEC (elsewhere in world).

Sources: http://www.cdc.gov/ncidod/dpd/parasites/lymphaticfilariasis/index.htm

http://www.cartercenter.org/health/lf/index.html

Just 50 cents campaign: http://www.globalnetwork.org/just50cents